Patent · US Active

Use of cathepsin K inhibition for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure

US9943522B2 · kind B2 · utility

2Cited by

1References

6Claims

0Family size

Assignee

Bayer Intellectual Property GmbH · DE

Inventors

Stefan Golz · Wetter (Ruhr), DE
Martina Delbeck · Essen, DE
Heinrich Meier · Wuppertal, DE
Andreas Geerts · Wuppertal, DE
Thomas MONDRITZKI · Essen, DE
Hubert Trübel · Wuppertal, DE

Key dates

Filing date	May 11, 2012
Grant date	Apr 17, 2018
Priority date	—
Expiry date	Jun 1, 2032

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P43/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates to the use of cathepsin K and/or cathepsin S inhibitors in a method for the treatment and/or prophylaxis of pulmonary hypertension and/or heart failure.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.